Overview TachoSil Paediatric Liver Trial (TC-019-IN) Status: Completed Trial end date: 2008-05-01 Target enrollment: Participant gender: Summary The overall objective is to assess the haemostatic efficacy and safety of TachoSil for control of local bleeding in paediatric patients undergoing surgical resection of the liver with our without segmental liver transplantation. Phase: Phase 3 Details Lead Sponsor: Nycomed